Friday 6 November 2026
Export IRTC’s income statement to Excel — free account
iRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
90.26
39.93
−30.67%
Follow IRTC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 6 |
| (36.57%) | (22.42%) | (9.63%) | (25.81%) | ||
| (4.57%) | (2.88%) | (1.36%) | (3.70%) | ||
ROIC |
(16.42%) | (9.79%) | (6.32%) | (11.42%) | |
Return on Tangible Assets |
(6.34%) | (3.94%) | (1.92%) | (5.49%) | |
Average Days of Receivables |
36.98 | 37.46 | 37.27 | 34.67 | |
Free Cash Flow per Share |
1.08 | 0.58 | 1.18 | 0.22 | |
Free Cash Flow |
34.52 | 18.75 | 38.98 | 7.38 | |
Capital Expenditures |
(46.34) | (43.83) | (47.02) | (48.18) | |
| Other line items | |||||
Cash ROIC |
2.49% | 1.38% | 2.73% | 0.53% | |
Accounts Receivable Turnover |
9.60 | 9.76 | 9.92 | 10.86 | |
Accounts Payable Turnover |
46.40 | 22.28 | 15.61 | 20.02 | |
Inventory Turnover |
12.33 | 11.98 | 11.52 | 11.08 | |
Average Days of Payables |
3.74 | 13.67 | 26.97 | 23.72 | |
Days of Inventory on Hand |
35.91 | 38.02 | 34.88 | 35.77 | |
Tax Rate |
0.02 | 0.03 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11.73% | 11.10% | 10.29% | 9.89% | |
Selling, General and Administrative Expense of Revenue |
65.93% | 64.54% | 62.25% | 60.32% | |
Share Based Compensation of Revenue |
11.82% | 10.97% | 10.13% | 9.62% | |
Interest Coverage |
(4.36) | (3.12) | (1.89) | (3.71) | |
Operating CF/Net income |
(1.82) | (2.25) | (6.17) | (1.44) | |
Depreciation/Fixed assets |
0.17 | 0.17 | 0.16 | 0.00 | |
Capex/Depreciation |
(1.75) | (1.67) | (1.78) | 0.00 | |
Revenue per Share |
23.35 | 24.24 | 25.09 | 25.80 | |
Operating CF per Share |
2.53 | 1.93 | 2.61 | 1.68 | |
Capex per Share |
(1.45) | (1.35) | (1.43) | (1.46) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 |
Columns are period end dates · fundamentals updated 5 Nov 2026